Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03539458 · ClinicalTrials.gov registry record · NA
Feasibility Study of the Tendyne Mitral Valve System in Mitral Annular Calcification
A NA study of Cardiovascular Diseases and Mitral Regurgitation, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- NA
- Development phase
- 11
- Enrollment target
- 4
- Study locations
NCT03539458 is a NA study of Cardiovascular Diseases and Mitral Regurgitation that has completed, run by Abbott Medical Devices. The registered enrollment target is 11 participants, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (100% lower). The trial reports 4 study locations across 4 states.
The verdict
NCT03539458, a NA study of Cardiovascular Diseases and Mitral Regurgitation, has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
- 4
- Study locations
Study Summary
This study is a prospective, single-arm, multi-center feasibility clinical study of the Tendyne Mitral Valve System for the treatment of eligible subjects with symptomatic, severe mitral regurgitation and severe mitral annular calcification (MAC). Subjects satisfying the study inclusion/exclusion criteria will undergo a procedure to implant the Tendyne mitral valve replacement device.
Conditions Studied
Interventions
- DEVICE Tendyne Mitral Valve System
Study Locations (4)
Georgia
- Emory University Hospital - Atlanta
Kansas
- Cardiovascular Research Institute of Kansas - Wichita
Minnesota
- Abbott Northwestern Hospital - Minneapolis
West Virginia
- West Virginia University - Morgantown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2018-10-10 |
| Est. Completion | 2024-06-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03539458
The ClinicalTrials.gov registry entry for NCT03539458 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (100% lower). The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 9 conditions, with Cardiovascular Diseases appearing as the primary indexed condition, and to 1 intervention - of which Tendyne Mitral Valve System is the first listed.
NCT03539458 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Georgia, Kansas, Minnesota.
Frequently Asked Questions
What is clinical trial NCT03539458 about?
NCT03539458 is a clinical study titled "Feasibility Study of the Tendyne Mitral Valve System in Mitral Annular Calcification". This study is a prospective, single-arm, multi-center feasibility clinical study of the Tendyne Mitral Valve System for the treatment of eligible subjects with symptomatic, severe mitral regurgitation and severe mitral annular calcification (MAC). Subjects satisfying the study inclusion/exclusion cr...
What is the current status of trial NCT03539458?
This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2018-10-10. Estimated completion is 2024-06-18.
What conditions does trial NCT03539458 study?
This clinical trial studies the following conditions: Cardiovascular Diseases, Mitral Regurgitation, Heart Valve Diseases, Mitral Valve Disease, Mitral Insufficiency.
What interventions are being tested in trial NCT03539458?
The interventions under investigation include: Tendyne Mitral Valve System (DEVICE).
Who is sponsoring clinical trial NCT03539458?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03539458 being conducted?
This trial has 4 study locations across Georgia, Kansas, Minnesota, West Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiovascular Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Influence of Chardonnay Marc Intake on Gut and Cardiometabolic Health
RECRUITING · NA
-
Identifying Strategies to Reduce Cardiovascular Risk Among Mothers of Young Children
RECRUITING · NA
-
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
RECRUITING · NA
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
-
Effects of Whole vs. Nonfat Milk Consumption on Body Composition in Children
RECRUITING · NA
-
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.